136 related articles for article (PubMed ID: 34340765)
1. Using proteomic and transcriptomic data to assess activation of intracellular molecular pathways.
Buzdin A; Tkachev V; Zolotovskaia M; Garazha A; Moshkovskii S; Borisov N; Gaifullin N; Sorokin M; Suntsova M
Adv Protein Chem Struct Biol; 2021; 127():1-53. PubMed ID: 34340765
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs.
Buzdin A; Sorokin M; Garazha A; Sekacheva M; Kim E; Zhukov N; Wang Y; Li X; Kar S; Hartmann C; Samii A; Giese A; Borisov N
Semin Cancer Biol; 2018 Dec; 53():110-124. PubMed ID: 29935311
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.
Buzdin AA; Prassolov V; Zhavoronkov AA; Borisov NM
Methods Mol Biol; 2017; 1613():53-83. PubMed ID: 28849558
[TBL] [Abstract][Full Text] [Related]
4. Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level.
Raevskiy M; Sorokin M; Zakharova G; Tkachev V; Borisov N; Kuzmin D; Kremenchutckaya K; Gudkov A; Kamashev D; Buzdin A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269755
[TBL] [Abstract][Full Text] [Related]
5. Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways.
Sorokin M; Borisov N; Kuzmin D; Gudkov A; Zolotovskaia M; Garazha A; Buzdin A
Front Genet; 2021; 12():617059. PubMed ID: 33633781
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of Molecular Pathway Activation Using RNA Sequencing Data.
Borisov N; Sorokin M; Garazha A; Buzdin A
Methods Mol Biol; 2020; 2063():189-206. PubMed ID: 31667772
[TBL] [Abstract][Full Text] [Related]
7. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing for research and diagnostics in clinical oncology.
Buzdin A; Sorokin M; Garazha A; Glusker A; Aleshin A; Poddubskaya E; Sekacheva M; Kim E; Gaifullin N; Giese A; Seryakov A; Rumiantsev P; Moshkovskii S; Moiseev A
Semin Cancer Biol; 2020 Feb; 60():311-323. PubMed ID: 31412295
[TBL] [Abstract][Full Text] [Related]
9. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
Manes NP; Nita-Lazar A
J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
[TBL] [Abstract][Full Text] [Related]
10. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
11. Utilization of Proteomic Technologies for Precision Oncology Applications.
Pierobon M; Wulfkuhle J; Liotta LA; Petricoin Iii EF
Cancer Treat Res; 2019; 178():171-187. PubMed ID: 31209845
[TBL] [Abstract][Full Text] [Related]
12. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.
Zhan X; Long Y; Lu M
J Proteomics; 2018 Sep; 188():30-40. PubMed ID: 28851587
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
14. Studies of complex biological systems with applications to molecular medicine: the need to integrate transcriptomic and proteomic approaches.
Silvestri E; Lombardi A; de Lange P; Glinni D; Senese R; Cioffi F; Lanni A; Goglia F; Moreno M
J Biomed Biotechnol; 2011; 2011():810242. PubMed ID: 20981256
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
16. [Transcriptomics and proteomics in studies of induced differentiation of leukemia cells].
Novikova SE; Zgoda VG
Biomed Khim; 2015; 61(5):529-44. PubMed ID: 26539862
[TBL] [Abstract][Full Text] [Related]
17. Food allergy and omics.
Dhondalay GK; Rael E; Acharya S; Zhang W; Sampath V; Galli SJ; Tibshirani R; Boyd SD; Maecker H; Nadeau KC; Andorf S
J Allergy Clin Immunol; 2018 Jan; 141(1):20-29. PubMed ID: 29307411
[TBL] [Abstract][Full Text] [Related]
18. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Seyhan AA; Carini C
J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
[TBL] [Abstract][Full Text] [Related]
19. Role of Proteomics in the Development of Personalized Medicine.
Jain KK
Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
